Instil Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Instil Bio

13/11/2024 14:16

* Instil Bio Inc  TIL.OQ  reported a quarterly adjusted loss
of
$3.54​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-10.40.  The mean expectation of four analysts for the
quarter was for a loss of $2.11 per share. Wall Street expected
results to range from $-3.08 to $-1.08 per share.
    * Reported revenue was zero​; analysts expected $950.00
thousand. 
    * Instil Bio Inc's reported EPS for the quarter was a loss
of
$3.54​.
    * The company reported a quarterly loss of $23.02 million.
    * Instil Bio Inc shares had fallen by 50.4% this quarter and
gained 338.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 26.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Instil Bio Inc is
120.00 
This summary was machine generated from LSEG data November 13 at
02:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -2.11          -3.54          Missed
 Jun. 30 2024      -2.98          -2.29          Beat
 Mar. 31 2024      -2.23          -3.74          Missed
 Dec. 31 2023      -2.84          -1.99          Beat